A 12 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of SKBE on atopic dermatitis in children

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003259

Enrollment

Registered

2018-10-12

Start date

2017-08-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subjects will be randomized to receive SKBE or placebo. Subjects will orally self-adminster SKBE or placebo 1 stick per day for 12weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subjects who agree the particpation in the trial and submit informed and consent before the beginning of the trial. 2) subjects over 2 years and under 12 years of age inclusive 3) Subjects scored 20~50 from SCORing of Atopic Dermatitis

Exclusion criteria

Exclusion criteria: 1) The patient who take the medicine that can affect the state of Atopic Dermatitis within recent 1 week. 2) Subjects which in the opinion investigator could affect preclude evluation of response

Design outcomes

Primary

Measure	Time frame
SCORing of Atopic Dermatitis total score	—

Secondary

Measure	Time frame
SCORing of Atopic Dermatitis objective score;SCORing of Atopic Dermatitis subjective score	—

Countries

Korea, Republic of

Contacts

Public ContactJungmin Bae

The Catholic University of Korea, St. Vincent's Hospital

jminbae@gmail.com+82-31-249-8209

Outcome results